Last reviewed · How we verify
Magnesium Diasporal (magnesium levulinate)
Magnesium Diasporal (generic name: magnesium levulinate) is a magnesium levulinate drug. It is currently in unknown development.
Magnesium Diasporal works by replenishing magnesium levels in the body, which is essential for various cellular functions and can help alleviate symptoms of magnesium deficiency.
Magnesium Diasporal, also known as magnesium levulinate, is a small molecule drug in the magnesium levulinate class. Its original development is attributed to Diasporal, but current ownership information is not available. The target and approved indications for this medication are unknown. It is unclear whether Magnesium Diasporal is FDA-approved or off-patent. Further research is necessary to determine its commercial status and key safety considerations.
At a glance
| Generic name | magnesium levulinate |
|---|---|
| Drug class | magnesium levulinate |
| Therapeutic area | Cardiovascular |
| Phase | unknown |
Mechanism of action
Magnesium is a crucial mineral that plays a key role in many bodily functions, including muscle and nerve function, heart rhythm, and bone health. When magnesium levels are low, it can lead to symptoms such as muscle cramps, weakness, and fatigue. By replenishing magnesium levels, Magnesium Diasporal can help alleviate these symptoms and support overall health.
Approved indications
Common side effects
Key clinical trials
- Magnesium Supplementation in Advanced Non-small Cell Lung Cancer (NSCLC) (PHASE2,PHASE3)
- Low-cost Screening and Image-guided Photodynamic Therapy (PDT) of Premalignant and Malignant Oral Lesions (PHASE2)
- Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients With Locally Advanced or Recurrent Colorectal Cancer (PHASE1,PHASE2)
- Portable Measurement of Protoporphyrin IX in the Skin
- Magnesium Deficiency In Patients Hospitalized in Internal Medicine Wards (PHASE4)
- Effect of Oral Magnesium on Anesthesia and Postoperative Analgesia After Surgical Removal of the Lower Third Molars. (PHASE1,PHASE2)
- Gliadel Wafer and Fluorescence-Guided Surgery With 5-ALA Followed by Radiation Therapy And Temozolomide in Treating Patients With Primary Glioblastoma (PHASE2)
- A Laser Detection for Bladder Cancer by (Photodynamic) Spectra of Urine (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Magnesium Diasporal CI brief — competitive landscape report
- Magnesium Diasporal updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Magnesium Diasporal
What is Magnesium Diasporal?
How does Magnesium Diasporal work?
What is the generic name of Magnesium Diasporal?
What drug class is Magnesium Diasporal in?
What development phase is Magnesium Diasporal in?
Related
- Drug class: All magnesium levulinate drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Cardiovascular